Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

NCT04861584 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Urinary Bladder Cancer

Interventions

DRUG: Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin

Sponsor

Zhujiang Hospital